SBC Medical Group Holdings Inc(SBC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 4:00 PM ET (Korea 10/31 05:00)
Full metrics table
| Index | RUT | P/E | 11.04 | EPS (ttm) | 0.48 | Insider Own | 81.55% | Shs Outstand | 102.6M | Perf Week | -0.09% |
| Market Cap | 0.54B | Forward P/E | 10.1 | EPS next Y | 13.93% | Insider Trans | - | Shs Float | 19.0M | Perf Month | 4.04% |
| Enterprise Value | 0.42B | PEG | 7.06 | EPS next Q | 0.12 | Inst Own | 4.26% | Short Float | 3.96% | Perf Quarter | 66.93% |
| Income | 0.05B | P/S | 3.1 | EPS this Y | -8.27% | Inst Trans | 131.76% | Short Ratio | 3.95 | Perf Half Y | 59.37% |
| Sales | 0.18B | P/B | 2.05 | EPS next 5Y | 1.43% | ROA | 13.58% | Short Interest | 0.75M | Perf YTD | 22.39% |
| Book/sh | 2.57 | P/C | 2.94 | EPS past 3/5Y | 138.04% - | ROE | 19.29% | 52W High | -8.94% ($5.79) | Perf Year | 55.6% |
| Cash/sh | 1.8 | P/FCF | 7.24 | Sales past 3/5Y | - | ROIC | 16.63% | 52W Low | 89.75% ($2.78) | Perf 3Y | -50.65% |
| Dividend Est. | - | EV/EBITDA | 6.15 | EPS Y/Y TTM | 46.87% | Gross Margin | 71.02% | Volatility(W/M) | 5.55% 4.96% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 2.41 | Sales Y/Y TTM | -6.92% | Oper. Margin | 37.34% | ATR (14) | 0.27 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.2 | EPS Q/Q | 337.82% | Profit Margin | 27.99% | RSI (14) | 51.66 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.31 | Sales Q/Q | 13.44% | SMA20 | -1.86% ($5.38) | Beta | 0.54 | Target Price | $8.75 |
| Payout | - | Debt/Eq | 0.18 | Earnings | 2026/8/13 | SMA50 | 8.38% ($4.87) | Rel Volume | 0.82 | Prev Close | $5.69 |
| Employees | 863 | LT Debt/Eq | 0.12 | EPS/Sales Surpr. | -13.87% 8.41% | SMA200 | 34.9% ($3.91) | Avg Volume(3M) | 0.19M | Price | $5.28 |
| IPO | 2022/9/26 | Option/Short | Yes/Yes | Trades | 1383 | Volume | 155,303 | Change | -7.29% |
💉 A healthcare operations support company that provides management services to a network of beauty and dermatology treatment clinics, primarily in Japan. Its business model is designed to enhance the operational efficiency of affiliated medical corporations through franchise operations, equipment and consumables procurement, and facility leasing. The company is listed on a US stock exchange.
Over the past 1 year, on the higher side
9% below its 1-year high.
Traded about as much as usual. That is 82% of its average volume.
SBC makes money exceptionally well
Of every $100 in sales, $37.34 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -8.3% this year.
Tap to view numbers
Within its industry, it looks cheap
For a company earning $100 a year, you would pay $1,104. Peers typically go for $2,151. Compared with its own 2-year average, it is 19% pricier now.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Bought 3 years ago, your return today would be -50.6%.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Institutions barely hold it
Institutions hold 4.3%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
IWC iShares Micro-Cap ETF <0.01% 
FLQS Franklin U.S. Small Cap Multifactor Index ETF <0.01% 
HDG ProShares Hedge Replication ETF <0.01% 
HONG Leverage Shares 2X Long HON Daily ETF <0.01% 
ITWO ProShares Russell 2000 High Income ETF <0.01% Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
HSBH HSBC Holdings plc ADRhedged 3M It ranks #8 of 21 in the industry
Based on market cap of $543M.
CRAI#7 CRA International Inc $1B PER 26.1 SBC#8 SBC Medical Group Holdings Inc $543M PER 11.0 
ROMA#9 Roma Green Finance Ltd $383M PER - 
PPHC#10 Public Policy Holding Company Inc $312M PER - 
FORR#11 Forrester Research Inc $210M PER - 
FAQ
What kind of company is SBC?
SBC belongs to the Industrials sector and operates in the Consulting Services industry.
What is the market cap of SBC?
The market cap of SBC is approximately $543M, ranking 3,069 within its sector.
What is the P/E ratio of SBC?
SBC has a P/E ratio of approximately 11.0x, which can be used to assess its valuation relative to the Industrials sector average.
What is the 52-week high and low for SBC?
SBC has recorded a 52-week high of $5.79 and a low of $2.78.
